WO2014001476A2 - Traitement thermique non destructif d'arbres pour arrêter la progression de maladies - Google Patents
Traitement thermique non destructif d'arbres pour arrêter la progression de maladies Download PDFInfo
- Publication number
- WO2014001476A2 WO2014001476A2 PCT/EP2013/063567 EP2013063567W WO2014001476A2 WO 2014001476 A2 WO2014001476 A2 WO 2014001476A2 EP 2013063567 W EP2013063567 W EP 2013063567W WO 2014001476 A2 WO2014001476 A2 WO 2014001476A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aesculi
- bacteria
- bacterial
- tree
- plant
- Prior art date
Links
- 238000010438 heat treatment Methods 0.000 title claims abstract description 39
- 206010061818 Disease progression Diseases 0.000 title description 2
- 230000005750 disease progression Effects 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 45
- 241000894007 species Species 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 18
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 12
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims description 48
- 208000015181 infectious disease Diseases 0.000 claims description 34
- 241000157280 Aesculus hippocastanum Species 0.000 claims description 30
- 235000010181 horse chestnut Nutrition 0.000 claims description 23
- 241000157282 Aesculus Species 0.000 claims description 22
- 241001332292 Pseudomonas amygdali pv. aesculi Species 0.000 claims description 14
- 230000000740 bleeding effect Effects 0.000 claims description 11
- 244000298715 Actinidia chinensis Species 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 240000007817 Olea europaea Species 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 4
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 4
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 4
- 241000207199 Citrus Species 0.000 claims description 4
- 241000588694 Erwinia amylovora Species 0.000 claims description 4
- 244000061600 Laurocerasus officinalis Species 0.000 claims description 4
- 241001290151 Prunus avium subsp. avium Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 241001148183 Pseudomonas savastanoi Species 0.000 claims description 4
- 244000088401 Pyrus pyrifolia Species 0.000 claims description 4
- 241000589634 Xanthomonas Species 0.000 claims description 4
- 235000019693 cherries Nutrition 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 244000007021 Prunus avium Species 0.000 claims description 3
- 235000010401 Prunus avium Nutrition 0.000 claims description 3
- 240000001987 Pyrus communis Species 0.000 claims description 3
- 235000014443 Pyrus communis Nutrition 0.000 claims description 3
- 244000052616 bacterial pathogen Species 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 235000011446 Amygdalus persica Nutrition 0.000 claims description 2
- 241000588698 Erwinia Species 0.000 claims description 2
- 241001327829 Erwinia pyrifoliae Species 0.000 claims description 2
- 235000008994 Laurocerasus officinalis Nutrition 0.000 claims description 2
- 241000218298 Magnolia virginiana Species 0.000 claims description 2
- 241000693079 Maloideae Species 0.000 claims description 2
- 235000002725 Olea europaea Nutrition 0.000 claims description 2
- 235000004098 Prunus caroliniana Nutrition 0.000 claims description 2
- 244000141353 Prunus domestica Species 0.000 claims description 2
- 235000011435 Prunus domestica Nutrition 0.000 claims description 2
- 240000005809 Prunus persica Species 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 241000589774 Pseudomonas sp. Species 0.000 claims description 2
- 241001478342 Pseudomonas syringae pv. actinidiae Species 0.000 claims description 2
- 235000011400 Pyrus pyrifolia Nutrition 0.000 claims description 2
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 claims description 2
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 2
- 241000220222 Rosaceae Species 0.000 claims description 2
- 241000985670 Xanthomonas arboricola pv. pruni Species 0.000 claims description 2
- 241000589655 Xanthomonas citri Species 0.000 claims description 2
- 235000020224 almond Nutrition 0.000 claims description 2
- 241000624151 Pseudomonas amygdali pv. morsprunorum Species 0.000 claims 1
- 241000589615 Pseudomonas syringae Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 47
- 244000052769 pathogen Species 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 12
- 239000011159 matrix material Substances 0.000 abstract description 11
- 230000012010 growth Effects 0.000 abstract description 6
- 238000011534 incubation Methods 0.000 abstract description 6
- 230000017074 necrotic cell death Effects 0.000 abstract description 6
- 230000004807 localization Effects 0.000 abstract description 5
- 241001133184 Colletotrichum agaves Species 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 79
- 238000011081 inoculation Methods 0.000 description 59
- 210000004027 cell Anatomy 0.000 description 47
- 210000001519 tissue Anatomy 0.000 description 45
- 208000027418 Wounds and injury Diseases 0.000 description 35
- 206010052428 Wound Diseases 0.000 description 32
- 235000010443 alginic acid Nutrition 0.000 description 28
- 229920000615 alginic acid Polymers 0.000 description 28
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 26
- 229940072056 alginate Drugs 0.000 description 26
- 230000003902 lesion Effects 0.000 description 26
- 241000589623 Pseudomonas syringae pv. syringae Species 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 16
- 239000005090 green fluorescent protein Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 229920005610 lignin Polymers 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 10
- 229930183415 Suberin Natural products 0.000 description 10
- 208000034158 bleeding Diseases 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 230000001338 necrotic effect Effects 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 210000001723 extracellular space Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000035882 stress Effects 0.000 description 8
- 229920002444 Exopolysaccharide Polymers 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 7
- 229960003669 carbenicillin Drugs 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000001018 virulence Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 108091006104 gene-regulatory proteins Proteins 0.000 description 6
- 102000034356 gene-regulatory proteins Human genes 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 238000004626 scanning electron microscopy Methods 0.000 description 5
- 229960002180 tetracycline Drugs 0.000 description 5
- 229930101283 tetracycline Natural products 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 4
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 4
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 4
- 230000002520 cambial effect Effects 0.000 description 4
- 230000004665 defense response Effects 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012809 post-inoculation Methods 0.000 description 4
- 150000003522 tetracyclines Chemical class 0.000 description 4
- 238000005571 anion exchange chromatography Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000003032 phytopathogenic effect Effects 0.000 description 3
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000034655 secondary growth Effects 0.000 description 3
- 230000007226 seed germination Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 241000296380 Laminaria hyperborea Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001491705 Macrocystis pyrifera Species 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 101100108611 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alg-8 gene Proteins 0.000 description 2
- 208000035415 Reinfection Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008952 bacterial invasion Effects 0.000 description 2
- QNBLWPGKPNANOY-UHFFFAOYSA-N benzene-1,3,5-triol;hydrochloride Chemical compound Cl.OC1=CC(O)=CC(O)=C1 QNBLWPGKPNANOY-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- UBXYXCRCOKCZIT-UHFFFAOYSA-N biphenyl-3-ol Chemical group OC1=CC=CC(C=2C=CC=CC=2)=C1 UBXYXCRCOKCZIT-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000001744 histochemical effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000013435 necrotic lesion Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003534 oscillatory effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 230000008659 phytopathology Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000018612 quorum sensing Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241000694298 Aesculus x carnea Species 0.000 description 1
- 101710141114 Alginate biosynthesis protein Alg44 Proteins 0.000 description 1
- 101710164152 Alginate biosynthesis protein AlgF Proteins 0.000 description 1
- 101710164285 Alginate biosynthesis protein AlgK Proteins 0.000 description 1
- 101710163893 Alginate biosynthesis protein AlgX Proteins 0.000 description 1
- 240000000782 Anisomeles indica Species 0.000 description 1
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100402795 Caenorhabditis elegans mtl-1 gene Proteins 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 108090000845 GDP-mannose 6-dehydrogenases Proteins 0.000 description 1
- 108010072039 Histidine kinase Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 108010038016 Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 101710186713 Probable alginate O-acetylase AlgJ Proteins 0.000 description 1
- 235000014441 Prunus serotina Nutrition 0.000 description 1
- 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
- 241000589612 Pseudomonas savastanoi pv. glycinea Species 0.000 description 1
- 241001395385 Pseudomonas savastanoi pv. savastanoi Species 0.000 description 1
- 108090000951 RNA polymerase sigma 70 Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- RCTGMCJBQGBLKT-UHFFFAOYSA-N Sudan IV Chemical compound CC1=CC=CC=C1N=NC(C=C1C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 RCTGMCJBQGBLKT-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- JDZJVWAHZYIHFA-UHFFFAOYSA-N [Br].C1(=CC=CC=C1)O Chemical compound [Br].C1(=CC=CC=C1)O JDZJVWAHZYIHFA-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 101150059055 algC gene Proteins 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000012639 bacterial effector Substances 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N hydroxylamine hydrochloride Substances Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- WCYJQVALWQMJGE-UHFFFAOYSA-M hydroxylammonium chloride Chemical compound [Cl-].O[NH3+] WCYJQVALWQMJGE-UHFFFAOYSA-M 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000028744 lysogeny Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 101150009573 phoA gene Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 108010004131 poly(beta-D-mannuronate) lyase Proteins 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000003537 structural cell Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G7/00—Botany in general
- A01G7/06—Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
Definitions
- the invention relates to the field of phytopathogenic control; more particularly in woody species such as shrubs and trees.
- aesculi is found as an epiphyte on leaves, flowers and fruits of the host tree [9].
- the bacterium can adopt an endophytic, pathogenic lifestyle in the presence of small wounds, for example leaf scars or superficial injuries caused by human activities [10,1 1]. Further potential entry points for the bacterium have been shown to include lenticels
- Wounded plant tissue can lead to desiccation and forms a potential entry point for pathogens. Therefore, it is of importance for plants to separate healthy from disrupted tissues.
- wounds or infection sites in tree barks can be sealed off by de novo periderm (consisting of phellem, phellogen and phelloderm) formation, which is considered a non-specific defence response [12].
- periderm consisting of phellem, phellogen and phelloderm
- Formation of a new periderm layer near infection courts in Aesculus bark has been observed, but appeared ineffective in preventing (further) bacterial invasion [4,11].
- cell wall reinforcing components are deposited by existing cells near wounds in many tree species [13-16].
- lignin and suberin are found as widespread components of initial wound-repair and may function in preventing water loss and further tissue collapse [13].
- lignin and suberin are found as widespread components of initial wound-repair and may function in preventing water loss and further tissue collapse [13].
- For horse chestnut the timing and nature of such structural cell wall reinforcements in a wound boundary zone have not been described and its possible role in preventing the development of bleeding disease is unknown.
- the present invention provides a method for the prevention or control of bacterial infection of tree species, comprising exposing a tree species or part thereof to a temperature not less than about 39°C for a period of time of 48 hours or more.
- the method provides a practical approach to treatment of woody species in situ.
- the invention provides a method for the prevention or control of bacterial infection of tree species, wherein the temperature is maintained substantially constant during the period of exposure. In preferred methods the temperature is maintained at 39°C for a period of 48 hours.
- the tree species, part thereof or seed may be exposed to the temperature by conductive heat transfer from an heat source; and/or radiative heat transfer from an heat source; optionally there being two or more sources of heat.
- the heat source may be lamps (e.g. infra-red lamps), hot air blowers, radiators, heated bars or coils and/or tubes filled with hot air, liquids or gels.
- lamps e.g. infra-red lamps
- the plant part or branch or trunk may be coated or painted with a radiation adsorptive layer which for aesthetic reasons of treating trees e.g. in parks and gardens is preferably removable, e.g. matt black paint which is preferably water soluble.
- the tree species or part thereof treatable by the method may be exposed to the temperature for the period of time by (a) placing the tree species or part thereof or seed into a temperature controlled chamber; and/or (b) placing an heat source in direct contact with at least a portion of a woody part of the tree.
- the source of heat may be a flexible linear heating element wound around the circumference of the woody part.
- the flexible linear heating element is a fluid filled tube and heated fluid is pumped through the tube.
- Temperature sensors may be used to control the supply of heated fluid to the heating elements to achieve substantially uniform temperatures for the desired length of time.
- bacterial infections treatable by the method can include but are not limited to infections caused by bacterial species selected from the following list; Pseudomonas syringae pv. morsprunorumplum in plum (Prunus domestica) or cherry (Prunus avium), Pseudomonas syringae pv. savastanoi (e.g. Pseudomonas savastanoi) in olive (Olea europaea), Pseudomonas syringae pv. actinidiae in Kiwi (Actinidia deliciosa) or Golden Kiwi (A. chinensis), Xanthomonas citri pv.
- citri i.e. Xanthomonas axonopoulos pv. citri
- Citrus spp. or Citrus hybrids Xanthomonas arboricola pv. pruni in laurel cherry or bay cherry (Prunus laurocerasus), peach (Prunus persica) or almond (Prunus amygdalus), Erwinia pyrifoliae in Asian pear tree (Pyrus pyrifolia) or Pyrus communis or Erwinia amylovora in species of subfamily Maloideae (family Rosaceae).
- the bacterial infection is caused by Pseudomonas spp., Xanthomonas spp. or Erwinia spp. and more particularly, is Pseudomonas sp. infection of Aesculus spp.
- the bacterial infection is Pseudomonas syringae; preferably Pseudomonas syringae pv. aesculi infection of Aesculus hippocastanum.
- the plant or plant part may exhibit Horse Chestnut Bleeding Disease.
- Plants or plant parts obtainable by the method described may be free of viable bacterial pathogen.
- Aesculus hippocastanum, a part thereof or seed obtainable by the method herein described are substantially free of viable Pseudomonas syringae pv. aesculi.
- the present invention also provides an apparatus for heating a woody tree or branch comprising a fiexible heating element connectable to a power or heat source, characterised in that in a first position prior to application in use to a tree or branch the fiexible heating element is substantially linear, and in a second position in use the fiexible heating element is substantially in the form of a coil around and in intimate contact with a circumferential portion of the tree trunk or a branch.
- Pseudomonas syringae pv. aesculi strains (listed in table 1) were grown in Lysogeny Broth (LB; [47]) at 28 °C and 180 rpm. E. coli strains (Table 1) were routinely cultured in LB at 37 °C and 225 rpm. Plasmid pMP4655 (obtained from the Department of Molecular Microbiology, Leiden University; Table 1) was introduced in E.coli DH5a and GM119 by electroporation. Antibiotics were added in the following concentrations unless stated otherwise: tetracycline, 40 ⁇ g/mL; carbenicillin, 100 ⁇ g/mL and kanamycin, 50 ⁇ g/mL. Strains were stored at -80 °C for long-term conservation.
- Transformation of P. s. pv. aesculi by triparental conjugation The two E. coli donor strains harbouring pMP4655, helper strain cel40 containing pRK2013 and recipient P. s. pv. aesculi strains were grown until late log phase. Antibiotics present in the initial culture medium were first removed by collecting cells at 1,000 x g for 5 min and resuspending them in their original culture volume of LB. All cultures were pelleted again and resuspended in 3% of their original culture volume of LB.
- Cb carbenicillin
- Km Kanamycin
- Tc Tetracycline
- Tra conjugal transfer functions
- Plant cultivation and inoculation For the analysis of the early defence response and bacterial invasion upon inoculation, experiments were conducted with one and two-year old horse chestnut (A. hippocastanum) seedlings. Plants were maintained at room temperature under natural light in containers with 5 L potting soil and watered weekly. Experiments were repeated three times. Eight plants in total were inoculated at various sites on the stem for sampling in time, two inoculations at opposite sides of the stem. At each sample moment (see 'Sampling, fixation and sectioning ' ') one set of opposite inoculation sites was removed. Plants were either mock-inoculated as a control (3 plants in total) or inoculated with P. s. pv. aesculi (5 plants in total).
- a superficial wound was inflicted on a surface sterilized part of the stem by making a small (2-3mm), diagonal cut with a downward angle using a sterile razorblade. Care was taken not to cut deeper than the cambial zone.
- These wounds were inoculated by pipetting 5 of sterile PBS or 5 PBS containing 10 cfu/mL P. s. pv. aesculi PD4818 into the wound fissure.
- Infection experiments with GFP expressing bacteria were performed on three separate occasions in climate cells using 6 two-year old horse chestnut seedlings maintained at 21 °C, 70-90 % RH and a 16 h light, 8 h dark cycle. Plants were sampled after 4 and 6 weeks to examine in planta behaviour of bacteria, and monitored over a period of 8 weeks.
- samples of stem were removed from the inoculated seedlings around the original inoculation site at 0, 1, 2, 3, 4, 6, 8 and 14 days after inoculation. For investigation of later stages, samples were taken at 2, 3, 4, 10 and 18 weeks after inoculation.
- the sampled pieces of stem were fixed in 4% w/v paraformaldehyde, 0.05% v/v glutaraldehyde and 0.01% v/v Triton X-100 in 0.1M phosphate buffer (pH 7.2) by vacuum infiltration (10 kPa).
- Sections were washed in PBS for 10 min, incubated in 0.1M hydroxyl-ammoniumchloride for 30 min and washed again in PBS for 5 min. Sections were blocked in 0.5% w/v Bovine Serum Albumin Fraction V (Sigma- Aldrich) for 30 min and rinsed twice with PBS for 15 min. Samples were incubated overnight at 4 °C in anti-PRIl -FITC diluted 1 :600 or 1 : 1200 in PBS, washed twice for 15 min and twice for 30 min in PBS. The sections were finally mounted on slides in glycerol Citifluor AF2 for microscopic observation. For vitality assessments liquid grown bacteria were stained with propidium iodide (Sigma) at a final concentration of 5 ⁇ for 5 min in the dark.
- P. s. pv. aesculi PD4818 and its pMP4655 harbouring derivative were cultured at 20 °C in either LB or minimal medium containing 20 mM NaCl, 20 mM phosphate buffer, 10 mM (NH 4 ) 2 S0 4 , 5 mM MgS0 4 , 10 mM fructose and 10 mM mannitol (pH 6.1) [50,51]. After 2-3 days, cultures were observed by fluorescence microscopy as described above or prepared for scanning electron microscopy by fixing 1 mL samples with 3% v/v glutaraldehyde dissolved in the appropriate medium.
- Cultures of 125 mL of P. s. pv. aesculi PD4818 were either grown in duplo in minimal medium for 5 days or in minimal medium for 3 days and then under salt stress (0.4 M NaCl in minimal medium) for 2 days. Cultures were centrifuged for 15 min (10,000 x g, RT) and three volumes of ice cold ethanol were added to the supernatant to precipitate the extracellular material o/n at 4 °C. The precipitate was collected after centrifugation (30 min, 10,000 x g, 4 °C) and subsequently dialyzed o/n (Medicell Visking, MWCO 12,000-14,000 Da) against dH 2 0.
- the amount of uronic acids was determined using the m-hydroxydiphenyl assay as described by Blumenkrantz and Asboe-Hansen [52] and galacturonic acid was used as standard.
- the sugar composition was determined in more detail by High Performance Anion Exchange Chromatography (HPAEC) using an ICS-3000 Ion Chromatography HPLC system equipped with a CarboPac PA-1 column (2 x 250 mm) in combination with a CarboPac PA guard column (2 x 25 mm) and a pulsed electrochemical detector in pulsed amperometric detection mode (Dionex). A flow rate of 0.3 mL min 1 was used and the column was equilibrated with 16 mM NaOH.
- HPAEC High Performance Anion Exchange Chromatography
- EXAMPLE 1 Lignin and suberin are deposited near the wound boundary
- bacteria were applied to small wounds inflicted on the stems of A. hippocastanum seedlings. The method of wounding did not cause irrecoverable damage, since mock inoculated wounds showed generation of a new periderm confluent with the existing one within 3 months (Fig. IB upper panel). Inoculated wounds did not exhibit such a recovery (Fig. IB lower panel).
- lignin is a major component of the early wound repair responses in A. hippocastanum bark.
- lignin another histological compound with autofluorescent properties that could potentially be of importance in the barrier lining the wound is suberin [13,14,17].
- Sudan IV stained sections were observed under fluorescence conditions whereupon suberin lamellae appeared in dim red, while lignin autofluorescence was unaltered (See materials and methods).
- Fig. 1E/F From the sixth day after inoculation and onwards suberin was found as a lamella against the cell wall of the cells that exhibited lignification earlier (Fig. 1E/F). The deposition was uniform and did not occlude pit fields (Fig. 1G), supporting that the lining of lignified and suberized cells around the wound perimeter functions in sealing off the wound from healthy tissues.
- the effectiveness of the cellular response in restraining pathogen invasion after wounding can be assessed when related to observations on bacterial proliferation.
- immunolabelling the spread of inoculated P. s. pv. aesculi was monitored. During the first 2 days after inoculation, the bacteria were still mainly localized on the wound surface, with some individual bacteria present several cell layers deeper (data not shown). At the fourth day after inoculation several scattered bacteria were found behind the developing barrier zone. These first signs of bacterial ingress were clearly discernible in samples taken 6 days post inoculation, in which small clusters of bacterial cells were found in intercellular spaces of parenchyma cells, evidently inward from the lignified and suberized lining (Fig. 2A, arrowheads). Besides the colonization of living tissues, bacterial clusters remained in the wound fissure (Fig. 2 A, arrows).
- EXAMPLE 4 P. syringae pv. aesculi is embedded in an extracellular matrix in planta
- alginate was the predominant polysaccharide in the extracellular material produced by P. s. pv. aesculi under salt stress.
- Previous studies point to the possible additional presence of glucuronic acid [22] which elutes approximately at the same time as mannuronic acid.
- glucuronic acid [22] which elutes approximately at the same time as mannuronic acid.
- rhamnose and glucose although at lower concentrations than alginate, were identified (Fig. 6). Minor traces of an unidentified sugar were also present.
- Alginate is often found to be produced by plant pathogenic Pseudomonas spp. when associated with their host [23-25]. Its secretion aids in retaining water and is thereby thought to contribute to bacterial colonization and symptom development [26].
- the ability of P. s. pv. aesculi to produce alginate was further supported by the presence of genes associated with its biosynthesis and regulation thereof as screened in silico. Sequence data of P. s. pv. aesculi strain 2250 [8] indicated that this strain has a full repertoire of genes encoding alginate biosynthesis and regulatory proteins with close homology to these of P. s. pv. tomato DC3000 (Table IB). Furthermore, most of the genes predicted to function in biosynthesis were found to be arranged in the canonical alginate biosynthesis operon structure [27].
- Alg8 alginate biosynthesis protein Alg8 ZP " 06478556 493 97%
- Alg44 alginate biosynthesis protein Alg44 ZP " 06478557 390 92%
- AlgE alginate biosynthesis protein AlgE ZP " 06478559 493 97%
- AlgG alginate biosynthesis protein AlgG ZP " 06478560 536 92%
- AlgX alginate biosynthesis protein AlgX ZP " 06478561 479 97%
- Algl alginate biosynthesis protein Algl ZP " 06478563 518 97%
- AlgJ alginate biosynthesis protein AlgJ ZP " 06478564 391 95%
- AlgQ anti-R A polymerase sigma 70 ZP 06477758 157 96%
- the barrier sometimes seemed a bit more faint near invading bacteria, hinting at pathogen-mediated degeneration (Fig. 2A). This could be facilitated by the various pathways for degradation of lignin-related compounds uncovered in the P. s. pv aesculi genome [8]. Although not determinative in restraining P. s. pv. aesculi invasion, presence of the observed barrier might still serve a beneficial, protective role. For instance, it could prevent water and mineral flow towards the bacteria, prevent diffusion of bacterial toxins and effectors to healthy plant tissues, reduce tissue digestibility and give rigidity, preventing further tissue collapse.
- Fig. 3D The bacterial cells found near the forefront of expanding infections were small and densely clustered.
- disease symptoms on the cellular level included occasional colonization of single phloem/cortex parenchyma cells by a large bacterial cluster (Fig. 2B, J).
- Fig. 2B, J The bacterial accumulations might be important in the infection process, since expression of pathogenic traits often requires a certain, quorum sensing coordinated, cell density [32]. That such a quorum sensing system may act within the observed bacterial clusters in horse chestnut tissues is supported by the quorum size described for P. syringae (down to -20 individuals [33]) and the ability of Indian P. s. pv. aesculi to produce N-acyl- homoserine lactones [34].
- the observed matrix may play a direct role in pathogenicity.
- One such function may be the suppression of host defence
- thermal treatment may be a feasible, non-invasive control method employable for disease management on a larger scale.
- a potential issue with applying heat-treatment under field conditions could lie in differences in temperature sensitivity that may occur among various isolates, as is reported for Erwinia amylovora [44].
- the extremely high genetic homogeneity among UK P. s. pv. aesculi isolates [8] implies that variation in heat-resistance among bacterial strains is minimal, suggesting heat-treatment of A. hippocastanum may be a widely applicable method.
- A Typical symptoms of P. syringae pv. aesculi associated bleeding disease observed on the trunk of an A. carnea tree, including bleeding of amber coloured sap and cracking of the bark (arrowheads). Photo taken in Sept. 2008 at N51° 57' 26"; E5° 34' 10".
- B Appearance of surface wounds on A. hippocastanum seedlings mock-inoculated (top panel) or inoculated with P. s. pv. aesculi PD5126 (bottom panel) after 3 months. While the seedling bark recovers when mock-inoculated by regeneration of periderm, the wounded tissue appears blackened and sunken when inoculated with P. s. pv. aesculi.
- L-N Longitudinal sections of the cambium region with bacteria in intercellular spaces of phloem parenchyma (L), ray parenchyma (M) and along phloem fibres (N), 3 weeks after inoculation.
- O P. s. pv. aesculi in intercellular spaces observed in a transversal section of the cambial zone at 4 weeks after inoculation.
- R-T Transversal sections of enclosures surrounded by periderm with bacteria ex planta at 4, 10 and 18 weeks after inoculation respectively.
- Figure 3 Behaviour of GFP-expressing P. syringae in planta
- A An A. hippocastanum seedling inoculated with strain PD4818-pMP4655 photographed after 2 months shows vertical lesion expansion (up to 6 cm in length) and tissue necrosis after removal of the outer tissues of the bark. The inoculation site is indicated with an arrowhead. Note the bending of the infection around the lower node. The scale bar indicates 1 cm.
- Figure 4 A fibrillar matrix produced in vitro by P. s. pv. aesculi enwraps aggregates of immobilized bacteria.
- FIG. 5 Growth of two Pseudomonas syringae pv. aesculi strains and their GFP-expressing derivatives. Overnight cultures of P. s. pv. aesculi PD4818, PD5126 and their derived transformants harbouring pMP4655 were diluted to an OD 6 oo of 0.005 in fresh LB. The optical density at 600 nm of the cultures was recorded during growth at 28 °C and 180 rpm. The presented values are means ( ⁇ standard deviation) of three replicates and an asterisk indicates significant differences as determined with Students 2-tailed t-test (P ⁇ 0.001).
- FIG. 6 High performance anion exchange chromatography of acid hydro lysed extracellular polysaccharide of Pseudomonas syringae pv. aesculi PD4818 cultivated without (A) and with salt stress (B) and acid hydrolysed alginate from Laminaria hyperborea (C) and Macrocystis pyrifera (D). Each subsequent plot has been shifted 2.4 minutes for clarity.
- the marked peaks represent: I, Rhamnose; II, Unidentified compound; III, Glucose; IV, Degradation pattern of alginate (guluronic acid and mannuronic acid).
- Figure 7 shows a young A. hippocastanum branch undergoing heat treatment in a climate chamber.
- Figure 8 shows a mature A. hippocastanum tree undergoing heat treatment outside using hoses transporting water at 40°C, wrapped around the trunk.
- Woodward S, Pocock S (1996) Formation of the ligno-suberized barrier zone and wound periderm in four species of European broad-leaved trees. European Journal of Forest Pathology 26: 97-105.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Ecology (AREA)
- Forests & Forestry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
L'invention concerne le traitement thermique non destructif d'arbres pour arrêter la progression de maladies. Certaines espèces bactériennes sont des pathogènes majeurs des arbres. L'établissement, la croissance et la qualité des arbres peuvent être affectés par l'apparition de ces maladies. Les arbres infectés présentent une nécrose importante du phloème et du cambium, qui peut conduire au final à un dépérissement terminal. L'emplacement endophytique et la capacité de ces pathogènes à créer une matrice protectrice les rend difficilement accessibles aux agents de lutte. La présente invention concerne des procédés et des appareils pour lutter contre ou stopper des infections bactériennes dans des arbres par un traitement thermique comprenant l'incubation de plantes ou de parties de plantes à environ 39 °C pendant une durée non inférieure à 48 heures.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13732160.0A EP2866550A2 (fr) | 2012-06-29 | 2013-06-27 | Traitement thermique non destructif d'arbres pour arrêter la progression de maladies |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1211638.0 | 2012-06-29 | ||
GBGB1211638.0A GB201211638D0 (en) | 2012-06-29 | 2012-06-29 | Heat treatment of tree and shrubs to stop or ameliorate progression of bacterial diseases |
GB1211710.7 | 2012-07-02 | ||
GBGB1211710.7A GB201211710D0 (en) | 2012-07-02 | 2012-07-02 | Heat treatment of trees and shrubs to stop or ameliorate progression of bacterial diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014001476A2 true WO2014001476A2 (fr) | 2014-01-03 |
WO2014001476A3 WO2014001476A3 (fr) | 2014-03-20 |
Family
ID=48700584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/063567 WO2014001476A2 (fr) | 2012-06-29 | 2013-06-27 | Traitement thermique non destructif d'arbres pour arrêter la progression de maladies |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2866550A2 (fr) |
WO (1) | WO2014001476A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101577529B1 (ko) | 2014-04-07 | 2015-12-17 | 순천대학교 산학협력단 | 참다래 궤양병균 검출용 키트 및 상기 키트를 이용한 참다래 궤양병의 진단방법 |
WO2017029373A1 (fr) * | 2015-08-18 | 2017-02-23 | Rede Investments Bv | Procédé de réduction de pathogènes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR35295E (fr) * | 1928-01-17 | 1929-12-31 | Appareil pour échauder les vignes, arbres et autres plantes | |
WO2006021225A1 (fr) * | 2004-08-24 | 2006-03-02 | Hartwig Pollinger | Procede et dispositif pour traiter des chenes-lieges |
-
2013
- 2013-06-27 WO PCT/EP2013/063567 patent/WO2014001476A2/fr active Application Filing
- 2013-06-27 EP EP13732160.0A patent/EP2866550A2/fr not_active Withdrawn
Non-Patent Citations (53)
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101577529B1 (ko) | 2014-04-07 | 2015-12-17 | 순천대학교 산학협력단 | 참다래 궤양병균 검출용 키트 및 상기 키트를 이용한 참다래 궤양병의 진단방법 |
WO2017029373A1 (fr) * | 2015-08-18 | 2017-02-23 | Rede Investments Bv | Procédé de réduction de pathogènes |
NL2015316B1 (en) * | 2015-08-18 | 2017-03-07 | Rede Invest B V | Method for treating pests and/or infections. |
CN108135139A (zh) * | 2015-08-18 | 2018-06-08 | 里德投资公司 | 用于减少病原体的方法 |
US20180242532A1 (en) * | 2015-08-18 | 2018-08-30 | Rede Investments B.V. | Method for Reducing Pathogens |
Also Published As
Publication number | Publication date |
---|---|
EP2866550A2 (fr) | 2015-05-06 |
WO2014001476A3 (fr) | 2014-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
An et al. | Mechanistic insights into host adaptation, virulence and epidemiology of the phytopathogen Xanthomonas | |
Cleary et al. | Light and scanning electron microscopy studies of the early infection stages of H ymenoscyphus pseudoalbidus on F raxinus excelsior | |
Travadon et al. | Susceptibility of cultivated and wild Vitis spp. to wood infection by fungal trunk pathogens | |
Brodersen et al. | Xylem vessel relays contribute to radial connectivity in grapevine stems (Vitis vinifera and V. arizonica; Vitaceae) | |
Renzi et al. | Bacterial canker on kiwifruit in Italy: anatomical changes in the wood and in the primary infection sites | |
Bishop et al. | An ultrastructural study of vascular colonization in three vascular wilt diseases I. Colonization of susceptible cultivars | |
Ghanem et al. | Mucilage and polysaccharides in the halophyte plant species Kosteletzkya virginica: localization and composition in relation to salt stress | |
Centeno et al. | Contrasting strategies used by lichen microalgae to cope with desiccation–rehydration stress revealed by metabolite profiling and cell wall analysis | |
Appezzato-da-Glória et al. | Underground systems of Asteraceae species from the Brazilian Cerrado1 | |
Czajkowski et al. | Virulence of ‘Dickeya solani’and Dickeya dianthicola biovar‐1 and‐7 strains on potato (Solanum tuberosum) | |
de Keijzer et al. | Histological examination of horse chestnut infection by Pseudomonas syringae pv. aesculi and non-destructive heat treatment to stop disease progression | |
Roeschlin et al. | Resistance to citrus canker induced by a variant of Xanthomonas citri ssp. citri is associated with a hypersensitive cell death response involving autophagy‐associated vacuolar processes | |
Dangl | Bacterial pathogenesis of plants and animals: Molecular and cellular mechanisms | |
McCully et al. | Cryo-scanning electron microscopy (CSEM) in the advancement of functional plant biology. Morphological and anatomical applications | |
Deering et al. | Examination of the internalization of Salmonella serovar Typhimurium in peanut, Arachis hypogaea, using immunocytochemical techniques | |
Lelis et al. | Studies on the colonization of axenically grown tomato plants by a GFP-tagged strain of Clavibacter michiganensis subsp. michiganensis | |
Catara et al. | Bacterial diseases | |
Czajkowski et al. | Downward vascular translocation of a green fluorescent protein-tagged strain of Dickeya sp.(biovar 3) from stem and leaf inoculation sites on potato | |
Lindberg et al. | Growth of Heterobasidion annosum through bark of Picea abies | |
WO2014001476A2 (fr) | Traitement thermique non destructif d'arbres pour arrêter la progression de maladies | |
Vigouroux et al. | First hybrid plane trees to show resistance against canker stain (Ceratocystis fimbriata f. sp. platani) | |
Rytkönen et al. | Infectivity, survival and pathology of Finnish strains of Phytophthora plurivora and Ph. pini in Norway spruce | |
Wydra et al. | Immunohistochemical changes in methyl-ester distribution of homogalacturonan and side chain composition of rhamnogalacturonan I as possible components of basal resistance in tomato inoculated with Ralstonia solanacearum | |
Rangel-Montoya et al. | Unravelling the colonization mechanism of Lasiodiplodia brasiliensis in grapevine plants | |
Martín et al. | Phenological and histochemical changes of Ulmus minor due to root absorption of phenol: Implications for resistance to DED |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2013732160 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13732160 Country of ref document: EP Kind code of ref document: A2 |